Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.
Saved in:
| Title: | Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. |
|---|---|
| Authors: | Pawlyn C; The Institute of Cancer Research, London, UK. charlotte.pawlyn@icr.ac.uk.; The Royal Marsden Hospital NHS Foundation Trust, London, UK. charlotte.pawlyn@icr.ac.uk., Schjesvold FH; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Cairns DA; Leeds Cancer Research UK Clinical Trials Unit of Leeds, Leeds, UK., Wei LJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Davies F; Perlmutter Cancer Center, NYU Langone, New York, NY, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA., Abdulhaq H; University of California, San Francisco, Fresno Campus, CA, USA., Mateos MV; University Hospital of Salamanca; IBSAL; Institute of Cancer Molecular and Cellular Biology; and CIBERONC, Salamanca, Spain., Laubach J; Dana-Farber Cancer Institute, Boston, MA, USA., Weisel K; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany., Ludwig H; Medical Department Center for Oncology, Hematology and Palliative Medicine, Wilhelminen Cancer Research Institute, Vienna, Austria., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jackson G; Northern Centre for Cancer Care, Newcastle Upon Tyne Hospitals Trust, Newcastle Upon Tyne, UK., Morgan G; Perlmutter Cancer Center, NYU Langone, New York, NY, USA., Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA. |
| Source: | Blood cancer journal [Blood Cancer J] 2024 Aug 12; Vol. 14 (1), pp. 134. Date of Electronic Publication: 2024 Aug 12. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-024-01109-4 |
